VR

Vaman Rao Mothe

Director DIN 00522509
DIN 00522509 First appointment Apr 2002
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2002
Shareholding value β€’β€’β€’β€’ Premium profile

About Vaman Rao Mothe

Data last updated:

Vaman Rao Mothe was a Managing Director at Indigene Pharmaceuticals Private Limited (from 2002) and Director at Indigene Biopharmaceuticals (India) Private Limited (from 2011).

DIN 00522509
First Appointment 24 Apr 2002
Oldest Company Age 24 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director24 Apr 20022002Strike Off
Director28 Jun 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Indigene Pharmaceuticals Private Limited
Indigene Biopharmaceuticals (India) Private Limited
Premium access

Shareholding and investment profile for Vaman Rao Mothe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vaman Rao Mothe

Vaman Rao Mothe was first appointed on 24 Apr 2002 as Managing Director at Indigene Pharmaceuticals Private Limited. The most recent appointment on record is 28 Jun 2011 at Indigene Biopharmaceuticals (India) Private Limited.

Vaman Rao Mothe held 2 earlier board appointments: Indigene Pharmaceuticals Private Limited (Managing Director, from 24 Apr 2002); Indigene Biopharmaceuticals (India) Private Limited (Director, from 28 Jun 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available